Discover the Future of Clinical Flow Cytometry at ICCS 2026
Visit the Waters booth #200 to explore a connected vision for the future of clinical flow cytometry, built on the principles of standardization, reproducibility, and workflow confidence.
From trusted routine testing to advanced biological characterization and next-generation cellular intelligence, discover how Waters is helping laboratories transform complex data into meaningful insights.
Stop by our booth to learn how you can:
- Gain confidence with reproducible results, standardized workflows, and greater efficiency.
Featured Solutions: BD FACSLyric™ Clinical Flow Cytometry System, BD FACSDuet™ Sample Preparation System, BD Horizon™ Real Dye ASR Reagents, BD FACSuite™ Clinical Software - Unlock higher-dimensional analysis with consistent, reproducible performance.
Featured Solutions: NEW - BD FACSDiscover™ A7 Cell Analyzer, BD Horizon™ Real Dye Research Reagents, BD Horizon™ Dri Chroma Reagents - Drive real-world impact with advanced applications for disease characterization and MRD research.
Featured Solutions: BD Cytognos™ MRD Workflows, BD Infinicyt™ Software - Discover new dimensions of biology through integrated imaging and flow cytometry.
Featured Solutions: BD FACSDiscover™ A8 Cell Analyzer, BD CellView™ Image Technology, FlowJo™ Software
Whether you're looking to standardize routine workflows, advance clinical applications, or explore the next generation of cellular analysis, our experts are ready to help.
Be sure to attend our corporate presentation
When: Sunday, October 4 at 1:00 P.M. ET
Where: Concerto A
Featured speaker:
Scott Bornheimer, PhD. Director, Medical & Scientific Affairs
Flow cytometry innovation from spectral standardization to imaging: a pathway to new applications
Flow cytometry innovation from spectral standardization to imaging: a pathway to new applications New technologies in flow cytometry are opening a new chapter in standardization and applications for clinical development. This presentation will explore the technical foundation and evidence behind spectral standardization across instruments, reagents, and software, and examine how these advances can improve existing flow assays and enable development of new types of flow biomarkers. In parallel, imaging capabilities are now available in combination with spectral flow cytometry, creating new opportunities for cell characterization. Technical considerations and emerging applications for imaging cytometry will be discussed. Finally, examples will highlight how flow cytometry is being applied to support the clinical development of new therapeutics and precision medicine treatment strategies.
Visit our poster sessions
| Poster Number | Abstract Title | Primary Author | Presenter |
| 119 | Assay Transfer of Two Tube 12-Color T-Cell Function Panel Adapted to Include CAR Detection Using a BD FACSLyric™ Flow Cytometer | Yang Zeng, PhD. Associate Director of Medical Affairs Waters Biosciences | Yang Zeng, PhD. Associate Director of Medical Affairs, Waters Biosciences |
| 238 | Reproducible 12-Color Immunophenotyping of Human Whole Blood Using SpectraComp™ Unmixing and Compensation Particles on the BD FACSLyric™ | Lorena Hidalgo, PhD. Senior Scientist Scientific Applications Waters Biosciences | Lorena Hidalgo, PhD. Senior Scientist Scientific Applications Waters Biosciences |
| 146 | Detector Setting Independent (DSI) scaling on the BD FACSDiscover™ A7 Cell Analyzer | Joshua Welsh, PhD. Senior Staff Scientist Waters Biosciences | Joshua Welsh, PhD. Senior Staff Scientist Waters Biosciences |
| 133 | Visualizing Measurable Residual Disease: CellView™ Imaging confirms the Single-Cell Origin of Rare Abnormal Plasma Cells | Siobahn Cashman, PhD. Senior Staff Scientist Waters Biosciences | Scott Bornheimer, PhD. Director, Medical & Scientific Affairs Waters Biosciences |
| 107 | Evaluation of interacting cells in peripheral blood by flow cytometry: an understudied attribute of human biology | Chip Lomas, PhD. Staff Scientist Scientific Applications | Scott Bornheimer, PhD. Director, Medical & Scientific Affairs Waters Biosciences |
| 142 | A Label-Free Foundation Model for Automated Viability Assessment and Functional Assays in Imaging Flow Cytometry | Keegan Owsley, PhD. Associate Principle Engineer, Advanced Technologies | Greg Field, PhD. Senior AI Engineer Waters Biosciences |
| 239 | From Discovery to Analytical Confidence | Aaron Middlebrook, PhD. Associate Principle Scientist, Waters Biosciences | Abby Kelliher, SCYM Associate Director, Clinical Solutions & CDx Waters Biosciences |
| 240 | Reproducibility on Research Spectral Cytometers: | Aaron Middlebrook, PhD. Associate Principle Scientist, Waters Biosciences | Scott Bornheimer, PhD. Director, Medical & Scientific Affairs Waters Biosciences |
Test for disclaimer inside events landing.